About OTCPharm
OTCPharm is a company based in Moscow (Russia) founded in 2013. OTCPharm offers products and services including Afobazol and Rinostop.
- Headquarter Moscow, Russia
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ао 'Отисифарм'
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OTCPharm
OTCPharm offers a comprehensive portfolio of products and services, including Afobazol and Rinostop.
Afobazol is utilized as an over-the-counter anti-anxiety preparation that is administered once daily, with its effects noted for managing anxiety symptoms.
Rinostop is employed for relieving nasal congestion, where various formulations are provided to address breathing difficulties and promote mucosal healing.
Funding Insights of OTCPharm
Detailed funding history for OTCPharm
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by OTCPharm
Investment portfolio details for OTCPharm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - OTCPharm
Detailed financials for OTCPharm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Otcpharm Comparisons
Peer comparison for OTCPharm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OTCPharm
Detailed competitors of OTCPharm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Otcpharm
Complete news archive for OTCPharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OTCPharm
OTCPharm was founded in 2013.
OTCPharm is headquartered in Moscow, Russia.
Olga Mednikova is the current CEO of OTCPharm.
OTCPharm was established in 2013 through the reorganization of Pharmstandard, a Russian pharmaceutical entity. Operations are centered in the OTC sector of the Russian pharmaceutical industry, with a portfolio encompassing over-the-counter medications and select prescription drugs across multiple therapeutic categories. Four manufacturing facilities are operated from Moscow, Russia, supporting distribution within the domestic market.
OTCPharm offers Afobazol and Rinostop.